On Demand Webinars
Building Characterization Assays to Support Early-Stage saRNA Development and QC Alignment
Presented by Yun-Ting Kao, Senior Scientist at Immunomic Therapeutics
07th October 2026
Leveraging Next-Generation Sequencing (NGS) for Adventitious Agent Testing: Pacira’s Quality Control Strategy and Lessons Learned
Presented by Po-Yi Ho, Associate Director / Analytical Development / Cell & Gene Therapies at Pacira Biosciences, and Quynh Ton, Ph.D, Regional Sales Director: NGS Application Specialist at Pathoquest
06th October 2026
Aseptic Manufacturing for mRNA, ADCs, and Novel Biologics
Presented by Francesco Cicirello, Senior Director, Global Quality Compliance – BioNTainer at BioNTech and Scott Harper, Director of Global Sales, Aseptic Filling, at Cytiva
29th September 2026
Analytical Assessment of Leachables in Biological Drug Products: FDA’s Approach to Reviewing Information and a Representative Review Case
Presented by Andrey Sarafanov, PhD., Principal Investigator at U.S. FDA, Center for Biologics Evaluation and Research, Sarah Brophy, Global Scientific Director, E&L Element Materials Technology
24th September 2026
Future Path for E&L per ISO 10993‑18: A Look at Emerging Technical Specifications
Presented by Sandi Schaible, President and Founder of Bonded in Science, LLC, Kevin Rowland, M.S, Executive Vice President and General Manager at Jordi Labs
22nd September 2026
Are We There Yet? A Digital Maturity Model for Enabling Process Monitoring and Artificial Intelligence in Biologics Manufacturing
Presented by Jack Prior, Head of Process Monitoring & Data/AI Strategy at Sanofi, Masaki Yamada, Head of Product at Invert
16th September 2026
From Error‑Prone Manual Steps to Flexible, Automated, Audit‑Ready Workflows: Delivering Better Results, Faster at genOway
Presented by Albane Flocon, Bioinformatics developer at genOway, Christel Merrouche, Head of preclinical processes at genOway and Stéphane Pitout - Director of Professional Sales (SciY)
02nd July 2026
Designed for More Than Launch: Accelerating Biosimilar Manufacturing at Scale
Presented by Mark Schofield, Cytiva, Director Science, Ingrid Long, Cytiva, Global Product Manager Bioprocess Downstream Hardware
22nd June 2026
Roundtable Discussion: Sterility Testing Challenges and Opportunities for ATMPs
Presented by Dr David Roesti, PhD. Microbiology Expert/Senior Technical Steward Manufacturing Science and Technology at Novartis Pharma AG, Irving Ford, VP of Quality & Compliance at Made Scientific, Friedrich von Wintzingerode, Director, ADQC Microbiological Sciences at Roche-Genentech, Sophie Drinkwater, Associate Director in Microbiology at AstraZeneca, Brian Conti, Product & Commercial Leader at Rapid Micro Biosystems , Dr. Joseph Pierquin, Founder and CTO of Redberry, part of Lonza and Stephane Dubreux, Pharm.D. / MBA, Scientific Affairs Director for Pharma Quality Control at bioMérieux
27th May 2026
USP General Chapter <665>: Separating Fact from Fiction
Presented by Desmond G Hunt, Senior Principal Scientist at US Pharmacopeia, Dr. Samuel Kikandi, Deputy Director- Principal Engineer at Sanofi
20th May 2026
